Tissue Eng Part A. 2008 Dec;14(12):2089-104. doi: 10.1089/ten.tea.2007.0383.
Over the past 20 years, tissue engineering (TE) has evolved into a thriving research and commercial development field. However, applying TE strategies to musculoskeletal (MSK) and craniofacial tissues has been particularly challenging since these tissues must also transmit loads during activities of daily living. To address this need, organizers invited a small group of bioengineers, surgeons, biologists, and material scientists from academia, industry, and government to participate in a two and half-day conference to develop general and tissue-specific criteria for evaluating new concepts and tissue-engineered constructs, including threshold values of success. Participants were assigned to four breakout groups representing commonly injured tissues, including tendon and ligament, articular cartilage, meniscus and temporomandibular joint, and bone and intervertebral disc. Working in multidisciplinary teams, participants first carefully defined one or two important unmet clinical needs for each tissue type, including current standards of care and the potential impact of TE solutions. The groups then sought to identify important parameters for evaluating repair outcomes in preclinical studies and to specify minimally acceptable values for these parameters. The importance of in vitro TE studies was then discussed in the context of these preclinical studies. Where data were not currently available from clinical, preclinical, or culture studies, the groups sought to identify important areas of preclinical research needed to speed the development process. This report summarizes the findings of the conference.
在过去20年里,组织工程学(TE)已发展成为一个蓬勃发展的研究与商业开发领域。然而,将TE策略应用于肌肉骨骼(MSK)和颅面组织一直极具挑战性,因为这些组织在日常生活活动中还必须传递负荷。为满足这一需求,组织者邀请了一小群来自学术界、工业界和政府的生物工程师、外科医生、生物学家和材料科学家参加为期两天半的会议,以制定评估新概念和组织工程构建体的通用及组织特异性标准,包括成功的阈值。参与者被分配到四个分组讨论小组,分别代表常见的受伤组织,包括肌腱和韧带、关节软骨、半月板和颞下颌关节,以及骨骼和椎间盘。在多学科团队中工作,参与者首先仔细确定每种组织类型一两个未满足的重要临床需求,包括当前的护理标准以及TE解决方案的潜在影响。然后,各小组试图确定在临床前研究中评估修复结果的重要参数,并明确这些参数的最低可接受值。随后,在这些临床前研究的背景下讨论了体外TE研究的重要性。在临床、临床前或培养研究目前尚无数据的情况下,各小组试图确定加速开发过程所需的临床前研究的重要领域。本报告总结了会议的成果。